Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Targeted Therapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
Chattanooga, Tennessee
This trial is designed to study the safety and effectiveness of different cancer treatments in people with NSCLC that can't be removed by surgery and have certain oncogenic mutations or high TMB.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.